Mark Doherty

2.4k total citations
37 papers, 1.4k citations indexed

About

Mark Doherty is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Mark Doherty has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 20 papers in Infectious Diseases and 13 papers in Health. Recurrent topics in Mark Doherty's work include Vaccine Coverage and Hesitancy (13 papers), Tuberculosis Research and Epidemiology (11 papers) and Influenza Virus Research Studies (10 papers). Mark Doherty is often cited by papers focused on Vaccine Coverage and Hesitancy (13 papers), Tuberculosis Research and Epidemiology (11 papers) and Influenza Virus Research Studies (10 papers). Mark Doherty collaborates with scholars based in Belgium, United States and United Kingdom. Mark Doherty's co-authors include Baudouin Standaert, Carlo Giaquinto, Philippe Buchy, Robert L. Coffman, Anthony L. Cunningham, Alimuddin Zumla, Peter Andersen, Robert S. Wallis, Giuseppe Del Giudice and Ruprecht Schmidt‐Ott and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Mark Doherty

36 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Doherty Belgium 20 610 604 335 303 164 37 1.4k
Nicolás Dauby Belgium 20 720 1.2× 499 0.8× 299 0.9× 376 1.2× 80 0.5× 101 1.6k
Patrick Zuber Switzerland 24 651 1.1× 733 1.2× 156 0.5× 494 1.6× 84 0.5× 52 1.6k
Samuel McConkey Ireland 25 590 1.0× 801 1.3× 426 1.3× 88 0.3× 239 1.5× 72 1.9k
Marguerite Massinga Loembé Gabon 22 606 1.0× 419 0.7× 314 0.9× 142 0.5× 183 1.1× 59 1.7k
Pierre Loulergue France 25 746 1.2× 981 1.6× 235 0.7× 442 1.5× 85 0.5× 61 1.7k
H. W. Doerr Germany 24 577 0.9× 996 1.6× 276 0.8× 87 0.3× 296 1.8× 67 1.8k
Tsehaynesh Messele Ethiopia 24 962 1.6× 609 1.0× 201 0.6× 66 0.2× 78 0.5× 64 1.8k
Theresa M. Rossouw South Africa 19 1.2k 1.9× 337 0.6× 278 0.8× 72 0.2× 283 1.7× 87 2.0k
Sarah Mbaeyi United States 15 655 1.1× 725 1.2× 88 0.3× 662 2.2× 123 0.8× 32 1.7k
Katia Bruxvoort United States 24 766 1.3× 491 0.8× 118 0.4× 328 1.1× 293 1.8× 106 1.9k

Countries citing papers authored by Mark Doherty

Since Specialization
Citations

This map shows the geographic impact of Mark Doherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Doherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Doherty more than expected).

Fields of papers citing papers by Mark Doherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Doherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Doherty. The network helps show where Mark Doherty may publish in the future.

Co-authorship network of co-authors of Mark Doherty

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Doherty. A scholar is included among the top collaborators of Mark Doherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Doherty. Mark Doherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doherty, Mark, Birgit Weinberger, Arnaud M. Didierlaurent, & Paul‐Henri Lambert. (2025). Age-related changes in the immune system and challenges for the development of age-specific vaccines. Annals of Medicine. 57(1). 2477300–2477300. 10 indexed citations
2.
3.
Aris, Emmanuel, et al.. (2024). Burden of vaccine-preventable diseases in adults (50+) in the United States: a retrospective claims analysis. BMC Public Health. 24(1). 2960–2960. 3 indexed citations
4.
Doherty, Mark, et al.. (2024). Sustaining the momentum for adult vaccination post-COVID-19 to leverage the global uptake of life-course immunisation: A scoping review and call to action. International Journal of Infectious Diseases. 142. 106963–106963. 10 indexed citations
5.
Doherty, Mark, Fiona Ecarnot, J. Gaillat, & Lois Privor-Dumm. (2024). Nonstructural barriers to adult vaccination. Human Vaccines & Immunotherapeutics. 20(1). 2334475–2334475. 5 indexed citations
6.
Crown, John, Ray McDermott, Janice M. Walshe, et al.. (2023). Pilot study of the implementation of G8 screening tool, Cognitive screening assessment and Chemotherapy Toxicity assessment in older adults with cancer in a Tertiary University Hospital in Ireland. Irish Journal of Medical Science (1971 -). 193(1). 45–50. 1 indexed citations
7.
Beck, Ekkehard, Nancy Devlin, Mark Doherty, et al.. (2022). Capturing the value of vaccination within health technology assessment and health economics: Literature review and novel conceptual framework. Vaccine. 40(30). 4008–4016. 20 indexed citations
8.
Doherty, Mark, et al.. (2022). Capturing the value of vaccination: impact of vaccine-preventable disease on hospitalization. Aging Clinical and Experimental Research. 34(7). 1551–1561. 7 indexed citations
9.
Sivakumaran, Dhanasekaran, Synne Jenum, Mário Vaz, et al.. (2020). Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes. Communications Biology. 3(1). 359–359. 17 indexed citations
10.
Chalmers, Natalia I., et al.. (2018). Person-centered care model in dentistry. BMC Oral Health. 18(1). 198–198. 50 indexed citations
11.
Doherty, Mark, Ruprecht Schmidt‐Ott, José Ignacio Santos, et al.. (2016). Vaccination of special populations: Protecting the vulnerable. Vaccine. 34(52). 6681–6690. 135 indexed citations
12.
Doherty, Mark, et al.. (2016). Vaccine impact: Benefits for human health. Vaccine. 34(52). 6707–6714. 185 indexed citations
13.
Cunningham, Anthony L., Nathalie Garçon, Oberdan Léo, et al.. (2016). Vaccine development: From concept to early clinical testing. Vaccine. 34(52). 6655–6664. 87 indexed citations
14.
16.
Doherty, Mark, et al.. (2012). Opinion - TB case detection: Can we remain passive while the process is active?. Pan African Medical Journal. 11(1). 2 indexed citations
17.
Doherty, Mark. (2011). Living with Voices: 50 Stories of Recovery. Journal of Psychiatric and Mental Health Nursing. 18(1). 94–95. 1 indexed citations
18.
Doherty, Mark, Robert S. Wallis, & Alimuddin Zumla. (2009). Biomarkers for tuberculosis disease status and diagnosis. Current Opinion in Pulmonary Medicine. 15(3). 181–187. 57 indexed citations
19.
Doherty, Mark, Anja Weinreich Olsen, Joachim Weischenfeldt, et al.. (2004). Comparative Analysis of Different Vaccine Constructs Expressing Defined Antigens fromMycobacterium tuberculosis. The Journal of Infectious Diseases. 190(12). 2146–2153. 48 indexed citations
20.
Doherty, Mark. (1995). T-cell regulation of macrophage function. Current Opinion in Immunology. 7(3). 400–404. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026